Related references
Note: Only part of the references are listed.The Current Crisis of Confidence in Antidepressants
Andrew A. Nierenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Suicidality and Risk of Suicide-Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report
Roger E. Meyer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data
Theo Stijnen et al.
STATISTICS IN MEDICINE (2010)
Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction
Lu Tian et al.
BIOSTATISTICS (2009)
Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team
Brenda J. Crowe et al.
CLINICAL TRIALS (2009)
The Treatment of Adolescent Suicide Attempters Study (TASA): Predictors of Suicidal Events in an Open Treatment Trial
David A. Brent et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2009)
Suicidality, depression screening, and antiepileptic drugs Reaction to the FDA alert
Bassel F. Shneker et al.
NEUROLOGY (2009)
Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells
Gerta Ruecker et al.
STATISTICS IN MEDICINE (2009)
Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
Marc Stone et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Smoking and suicide: A brief overview
John R. Hughes
DRUG AND ALCOHOL DEPENDENCE (2008)
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Robin Christensen et al.
LANCET (2007)
Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants
Kelly Posner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Factors in the assessment of suicidality in youth
Kelly Posner et al.
CNS SPECTRUMS (2007)
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Michael J. Bradburn et al.
STATISTICS IN MEDICINE (2007)
Non-suicidal self-injury among adolescents: Diagnostic correlates and relation to suicide attempts
Matthew K. Nock et al.
PSYCHIATRY RESEARCH (2006)
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data (vol 23, pg 1351, 2004)
Michael Sweeting et al.
STATISTICS IN MEDICINE (2006)
Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials
GF Liu et al.
STATISTICS IN MEDICINE (2006)
Suicidality in pediatric patients treated with antidepressant drugs
TA Hammad et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: A meta-analysis
AD Mosholder et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)
Accounting for multiplicities in assessing drug safety: A three-level hierarchical mixture model
SM Berry et al.
BIOMETRICS (2004)
A note on competing risks in survival data analysis
JM Satagopan et al.
BRITISH JOURNAL OF CANCER (2004)
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data
MJ Sweeting et al.
STATISTICS IN MEDICINE (2004)
The InterSePT scale for suicidal thinking reliability and validity
JP Lindenmayer et al.
SCHIZOPHRENIA RESEARCH (2003)
Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports
A Khan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Clinical correlates of inpatient suicide
KA Busch et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
The Suicidal Behaviors Questionnaire-Revised (SBQ-R): Validation with clinical and nonclinical samples
A Osman et al.
ASSESSMENT (2001)
Epidemiology of completed and attempted suicide: toward a framework for prevention
EK Moscicki
CLINICAL NEUROSCIENCE RESEARCH (2001)
Risk of suicide in users of β-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors
HT Sorensen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: An analysis of the Food and Drug Administration database
A Khan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Zero-inflated Poisson and binomial regression with random effects: A case study
DB Hall
BIOMETRICS (2000)
Share Paper
